4:41 PM
 | 
Jul 07, 2014
 |  BC Extra  |  Top Story

Japan approves drugs for cancer, HCV, TB

Japan's Ministry of Health, Labor and Welfare (MHLW) approved several new drugs on Friday, including Opdivo nivolumab from Ono Pharmaceutical Co. Ltd. (Tokyo:4528) to treat unresectable melanoma. The approval requires Ono to conduct a postmarketing survey and collect safety and efficacy data from an undisclosed number of patients. Ono said this is the first approval worldwide for a programmed cell death 1 ( PDCD1; PD-1;

Read the full 335 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >